Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma…
Take a look at the 1-year chart of Alexion (NASDAQ: ALXN) below with my added notations…
Continue reading at STOCKNEWS.com